New Additions to IONICON Trace Gas Analyzer Series to be showcased at Pittcon 2015
26 January 2015 | By IONICON
A fast GC add-on for PTR-TOFMS trace gas analyzers and the new PTR-QiTOF are now available...
List view / Grid view
News
Doctors fear that new health tech is turning UK into a nation of “worried well”
26 January 2015 | By Lukats and Shapiro
Doctors fear the wealth of health data from the internet and smartphones could be creating a new army of “worried well”, a survey for the Astellas Innovation DebateTM shows...
Santen receives a positive CHMP opinion for EU marketing authorization for Ikervis®
26 January 2015 | By NewCap.
Santen SAS announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorization for Ikervis®...
Alliance Pharma appoints Nigel Clifford as an independent Non-Executive Director
26 January 2015 | By Alliance Pharma plc
Alliance Pharma plc has appointed Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.
Novartis drug Jakavi® recommended by CHMP for EU approval to treat adults with rare blood cancer polycythemia vera
23 January 2015 | By Novartis
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Jakavi® (ruxolitinib) for the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea...
Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial
23 January 2015 | By GlaxoSmithKline
GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa...
Treatment market for Irritable Bowel Syndrome could hit $1.5 billion by 2023, says GlobalData
22 January 2015 | By GlobalData
The global therapeutics market for Irritable Bowel Syndrome (IBS) is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023, representing a high Compound Annual Growth Rate (CAGR) of almost 9.9%, says research and consulting firm GlobalData...
CAMO Software exhibiting at IFPAC 2015
CAMO Software will be exhibiting at the IFPAC® Annual Meeting in Arlington, VA (Washington D.C.) January 25-28. CAMO Software can be found in booth #709...
Sunesis Pharmaceuticals selects Quotient Clinical’s real-time adaptive manufacturing to support its vosaroxin clinical mass balance/ADME program
21 January 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, and Sunesis Pharmaceuticals have announced the initiation of a clinical mass balance/ADME trial for vosaroxin – a candidate therapeutic for acute myelogenous leukemia (AML)...
Once daily treatment option made available for up to one million adult Britons with type 2 diabetes and moderate chronic kidney disease
21 January 2015 | By Aurora
A once daily injection has been approved for adults with type 2 diabetes and moderate renal impairment (stage 3 chronic kidney disease) in the UK...
Pharmalink announces an Open Investigational New Drug (IND) application for Nefecon®
21 January 2015 | By Citigate Dewe Rogerson
Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that its IND for Nefecon® is now open with the US Food & Drug Administration...
Bristol-Myers Squibb appoints Giovanni Caforio, M.D., Chief Executive Officer, effective May 5; Lamberto Andreotti to become Chairman
21 January 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a number of leadership changes approved by its board of directors and effective at the close of the annual Shareholders’ Meeting on May 5...
Orphan drug prices facing increased scrutiny after historic year for approvals, says GlobalData analyst
21 January 2015 | By GlobalData
With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set to come under increased scrutiny, says an analyst with research and consulting firm GlobalData...
Rotary releases US$8.1 million to end polio in Nigeria
21 January 2015 | By Distributed by APO (African Press Organization) on behalf of Rotary International
Nigeria marks progress, having gone six months without a case of polio...
Shire (SHP LN): Pipeline to deliver 2015 catalysts; PT +17% to 5500p
20 January 2015 | By Edelman
We believe NPS is a solid acquisition and are confident management can extract significant Revenue and operating synergies, with focus on the 24 Jan FDA action on Natpara...
